AKT1 and breast cancer: On the contrary, the human Akt inhibitor (Cap) significantly affected the non-mitochondrial respiration level in MCF7 cells, whereas olaparib (Op) did not affect either of the breast cancer cell lines in the level of non-mitochondrial respiration (Figure 5g,h).